Search clinical trials for: dmard

Total 82 results

Barts & The London NHS Trust

Completed

Ultrasound Utility in Routine Clinical Practise

Arthritis, Rheumatoid | Ultrasonography
Diakonhjemmet Hospital
The Research Council of Norway; South-Eastern Norway Regional Health Authority

Completed

Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis (ARCTIC REWIND)

Rheumatoid Arthritis

Norway
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer; Immunex Corporation

Completed

Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Rheumatoid Arthritis
Mycenax Biotech Inc.

Unknown

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

Combination With DMARDs

Taiwan
National Institute of Medical Sciences and Nutrition...

Recruiting

INCMNSZ - Rheumatoid Arthritis Cohort (IRAC)

Rheumatoid Arthritis | Early Rheumatoid Arthritis

Mexico
Biologics & Biosimilars Collective Intelligence...
Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim and other collaborators

Completed

Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis

Rheumatoid Arthritis | Psoriasis | Psoriatic Arthritis | Inflammatory Bowel Disease | Ankylosing Spondylitis
Pfizer

Completed

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

Rheumatoid Arthritis

Denmark
Hoffmann-La Roche

Completed

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

Juvenile Idiopathic Arthritis
University Hospital, Toulouse

Unknown

Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase

Rheumatoid Arthritis

France
SetPoint Medical Corporation

Active, not recruiting

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis (RESET-RA)

Rheumatoid Arthritis

United States
University of Zurich

Unknown

Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement

Rheumatoid Arthritis

Switzerland
University of Alabama at Birmingham
Patient-Centered Outcomes Research Institute

Recruiting

RA-PRO PRAGMATIC TRIAL (RA-PROPR)

Rheumatoid Arthritis

United States, Canada
University of Cagliari
University of Turin, Italy; University Hospital, Udine, Italy; Azienda Sanitaria... and other collaborators

Unknown

Ultrasound in Psoriatic Arthritis Treatment (UPSTREAM)

Arthritis, Psoriatic | Ultrasonography | Minimal Disease, Residual

Italy
Hoffmann-La Roche

Completed

A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

Rheumatoid Arthritis

Portugal
Hoffmann-La Roche

Terminated

A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Finland
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Rheumatoid Arthritis

Italy
Liga Panamericana de Asociaciones de Reumatologia...

Recruiting

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (PREJAK)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis

Argentina
DNAlytics
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Unknown

Predictive Analytics for Theranosis in RA (PAnTheRA)

Rheumatoid Arthritis

Belgium, Spain
Hoffmann-La Roche

Completed

A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488 (RITACT)

Arthritis, Rheumatoid

Brazil
Alliancells Bioscience Corporation Limited

Unknown

Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

China
Diakonhjemmet Hospital
Oslo University Hospital; University Hospital of North Norway; Helse Nord-Trøndelag... and other collaborators

Recruiting

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors (RIMRA)

Immune-related Adverse Event

Norway
Uppsala University

Completed

Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)

Spinal Fractures | Ankylosing Spondylitis
Newcastle-upon-Tyne Hospitals NHS Trust
Wellcome Trust; Newcastle University

Completed

Biomarkers of Remission in Rheumatoid Arthritis (BioRRA) (BioRRA)

Rheumatoid Arthritis

United Kingdom
Fundación Santa Fe de Bogota

Unknown

Predictive Factors for COVID-19 in Rheumatology

Covid19 | Rheumatic Diseases
Hoffmann-La Roche

Completed

A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Rheumatoid Arthritis

United States
Eli Lilly and Company

Completed

A Study in Moderate to Severe Rheumatoid Arthritis Participants (RA-BUILD)

Rheumatoid Arthritis

United States, India, Hungary, Puerto Rico, Romania, Poland, Belgium, Canada, Russian Federation, Spain, Japan, Argentina, Croatia, Australia, Taiwan, Italy, Czechia, Mexico, Korea, Republic of, United Kingdom, Slovakia, Germany, Po...
Kasr El Aini Hospital

Active, not recruiting

Biologic Therapy in Pediatric JIA Uveitis

Juvenile Idiopathic Arthritis Associated Uveitis

Egypt
Nanfang Hospital of Southern Medical University
Southern Medical University, China

Unknown

Long-term Prognosis and Quality of Life in Early Rheumatoid Arthritis Patients Treated by 2015 ACR Guideline (LELAND) (LELAND)

Rheumatoid Arthritis
Eli Lilly and Company

Completed

A Moderate to Severe Rheumatoid Arthritis Study (RA-BEACON)

Rheumatoid Arthritis

United States, Israel, Turkey, Spain, Puerto Rico, Germany, Italy, France, Japan, Mexico, United Kingdom, Austria, Denmark, Poland, Australia, Greece, Switzerland, Argentina, Korea, Republic of, Belgium, Canada, Netherlands
Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants

Rheumatoid Arthritis

Italy
Hoffmann-La Roche

Completed

A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

Italy
Assistance Publique - Hôpitaux de Paris
French Society of Rheumatology

Completed

Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study (STRASS)

Rheumatoid Arthritis

France
Asan Medical Center

Unknown

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Cancer | Lung Cancer Metastatic | Immunotherapy

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Rheumatoid Arthritis

Russian Federation
JW Pharmaceutical

Completed

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
Charite University, Berlin, Germany
dfg

Unknown

New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

Reactive Arthritis

Germany
Chengdu PLA General Hospital

Unknown

Compliance of Traditional Chinese Medicine in Young Patients With Rheumatic Diseases

Chronic Rheumatic Diseases

China
National and Kapodistrian University of Athens

Recruiting

Cortisol Circadian Rhythm in Patients With RA (CortRyRA)

Rheumatoid Arthritis

Greece
Pfizer

Completed

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX (ORAL1069)

Arthritis, Rheumatoid

United States, Spain, Taiwan, Bulgaria, Czechia, Hungary, India, Korea, Republic of, Malaysia, Slovakia, Ukraine, Germany, Canada, Argentina, Australia, Thailand, Philippines, Puerto Rico, Brazil, Colombia, Chile, Costa Rica, Mexico, New... and more
Fundación Eduardo Anitua

Not yet recruiting

Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva (PRGF)

Lichen Sclerosus of Vulva
ImmuneMed, Inc.

Not yet recruiting

A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug)

Moderate to Severe Rheumatoid Arthritis

Netherlands
Shenzhen Hornetcorn Bio-technology Company, LTD
Futian People's Hospital

Unknown

Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis

Rheumatoid Arthritis

China
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis (ROSE)

Rheumatoid Arthritis

United States, Puerto Rico
Zhang, Xiao, M.D.
Xijing Hospital; Tianjin Medical University General Hospital; Central South University

Unknown

Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients (INNOVATION)

Rheumatoid Arthritis（RA）

China
JW Pharmaceutical

Completed

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
Hoffmann-La Roche

Completed

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

France, Germany, Italy, Spain, United Kingdom, Hong Kong, United States, Colombia, Brazil, Canada, New Zealand, South Africa, Philippines, Russian Federation, Thailand, Singapore, Bulgaria, Mexico, Australia, Lithuania, Poland, Ar... and more
Janssen Research & Development, LLC

Terminated

An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement (RECOVERY)

Spondylitis, Ankylosing

China
Qilu Hospital of Shandong University

Active, not recruiting

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Connective Tissue Diseases | Interstitial Lung Disease | Pirfenidone

China
Sabine Dieperink
University of Copenhagen; University of Aarhus; Statens Serum Institut

Completed

Bloodstream Infections in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis | Staphylococcus Aureus Bacteremia
Ain Shams University
Future University in Egypt

Unknown

Metformin Use in Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt

Search clinical trials for: dmard

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations